Continental Investors Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Buy
366
+32
+10% +$32.7K 0.34% 53
2026
Q1
$323K Buy
334
+22
+7% +$22.3K 0.31% 62
2025
Q4
$324K Buy
312
+18
+6% +$17.2K 0.42% 56
2025
Q3
$239K Buy
294
+15
+5% +$11.2K 0.35% 64
2025
Q2
$217K Buy
279
+10
+4% +$7.77K 0.39% 60
2025
Q1
$223K Buy
+269
New +$224K 0.44% 59

Other funds holding LLY

Continental Investors Services's LLY Position: Q2 2026 in Review

Continental Investors Services increased its Eli Lilly (LLY) stake by 9.6% in Q2 2026, buying an estimated $32.7K and bringing the position to 366 shares worth $428K. The position accounts for 0.34% of the portfolio, ranked #53.

Continental Investors Services first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Continental Investors Services held 366 shares of Eli Lilly worth $428K as of Q2 2026.
  • Continental Investors Services bought 32 Eli Lilly shares in Q2 2026, an estimated $32.7K.
  • Eli Lilly made up 0.34% of Continental Investors Services's portfolio in Q2 2026, its #53 holding.
  • Continental Investors Services first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Continental Investors Services's 13F filing for Q2 2026, filed 13 Aug 2026.